FJ
Fox Jennifer Lynne
Cadre supérieur
OtherF
Insider track record
ExecutiveAcross 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Fox Jennifer Lynne, Cadre supérieur. Insider active across 2 companies, notably Emergent BioSolutions Inc.. Aggregated, 15 disclosures have been recorded. Activity tracked since 1 March 2022. The latest transaction was filed on 3 September 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations15 total
4,435 shares@ US$6.80Common StockSEC:0001914879-25-000004:0
63,145 shares0Common StockSEC:0001628280-25-013147:0
61,771 shares0Common StockSEC:0001914879-24-000007:0
15,000 shares0Common StockSEC:0001367644-24-000126:0
2,376 shares@ US$6.1928.1% of flowCommon StockSEC:0001367644-24-000108:0
4,103 shares@ US$3.2325.5% of flowCommon StockSEC:0001367644-24-000019:0
229 shares@ US$2.741.2% of flowCommon StockSEC:0001367644-24-000010:0
413 shares@ US$2.001.6% of flowCommon StockSEC:0001367644-23-000191:0
24,616 shares0Common StockSEC:0001367644-23-000123:0
6,154 shares0Common StockSEC:0001367644-23-000067:0
1,005 shares@ US$12.3824.4% of flowCommon StockSEC:0001367644-23-000060:0
231 shares@ US$14.306.5% of flowCommon StockSEC:0001367644-23-000034:0
14,045 shares0Common StockSEC:0001367644-22-000155:0
416 shares@ US$15.0012.7% of flowCommon StockSEC:0001367644-22-000146:0
7,583 shares0Common StockSEC:0001367644-22-000048:0
About Fox Jennifer Lynne
Jennifer Lynne Fox serves as Executive Vice President, General Counsel, and Corporate Secretary at Emergent BioSolutions Inc. She is responsible for overseeing the company's legal affairs and compliance while playing a key role in managing stakeholder relationships. Her expertise contributes to the overall strategy of the company.